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Background: Pyrexia, algesia and inflammation are associated with several pathological conditions. Synthetic drugs
available for the treatment of these conditions cause multiple unwanted effects. Several studies are ongoing
worldwide to find natural healing agents with better safety profile. The current study was thus aimed at evaluating
antipyretic, analgesic and anti-inflammatory activities of the methanolic extract of whole plant of V. betonicifolia
(VBME).
Methods: VBME was employed to assess antipyretic activity in yeast induced hyperthermia. Analgesic profile was
ascertained in acetic acid induced writhing, hot plat and tail immersion test. Nevertheless, the anti-inflammatory
activity was tested in carrageenan induced paw edema and histamine induced inflammatory tests. BALB/c mice
were used at test doses of 100, 200 and 300mg/kg body weight intra peritoneally (i.p).
Results: In yeast induced pyrexia, VBME demonstrated dose dependently (78.23%) protection at 300mg/kg, similar
to standard drug, paracetamol (90%) at 150mg/kg i.p. VBME showed a dose dependent analgesia in various pain
models i.e. acetic acid, hot plat and tail immersion having 78.90%, 69.96% and 68.58% protection respectively at
300mg/kg. However, the analgesic action of VBME was completely antagonized by the injection of naloxone like
opiate antagonists. Similarly carrageenan and histamine induces inflammation was significantly antagonized by
VBME, 66.30% and 60.80% respectively at 300mg/kg.
Conclusions: It is concluded that VBME has marked antipyretic, analgesic and anti-inflammatory activities in various
animal models and this strongly supports the ethnopharmacological uses of Viola betonicifolia as antipyretic,
analgesic and anti-inflammatory plant.
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Over the centuries, phytopharmaceuticals have been uti-
lized by different communities of the world [1]. The local
communities of different regions of Pakistan have been
using medicinal plants as a primary source of their health
care system and infact these medicinal plants are used to
cure a large number of diseases [2]. In Pakistan, this trend
is well established in the name of Hikmat/Tabib and ap-
proximately, 600–1000 medicinal plants of the country
have been used in the management of different pathological
conditions by more than 40,000 registered and a large
number of unregistered Hakims or Tabib [3]. This practice* Correspondence: saeedrph2000@yahoo.com
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distribution, and reproduction in any mediumis based on experiences, without any scientific evidence and
therefore, need proper validation on scientific grounds [4].
V. betonicifolia belongs to family Violaceace locally which
is known as banafsha. V.betonicifolia is found naturally in
various countries of the world like Pakistan, India, Nepal,
Srilanka, China, Malaysia and Australia. In Pakistan, it is
available in Swat, Hazara and Dir districts. The folk use of
this plant is antipyretic, astringent, diaphoretic, anticancer
and purgative. It has been used in the treatment of various
neurological disorders including epilepsy and insomnia [5].
Additionally, it has been used in the treatment of sinusitis,
skin and blood disorders and pharyngitis [6]. Roots are
used for kidney diseases, pneumonia and bronchitis. Flow-
ers are recommended for the treatment of asthma, cough
and colds while leaves are useful for the treatment of boils
[7]. Recently we have tested the crud methanolic as well as
the subsequent solvent fraction of V. betonicifolia forntral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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was designed to provide scientific evidence to the ethno-
botanical uses of the plant in the treatment of pyrexia, alge-
sia and inflammation in various animal models.
Methods
Chemicals
Paracetamol (Tianjin Bofa Pharmaceutical Co, Lit., China),
Diclofenac sodium (Suzhou Ausun Chemical Co, Lit.,
China), Acetic acid, Brewer’s yeast (Merck Germany), Car-
rageenan (Sigma Lambda, USA), Histamine (Alfa Aesar -
A Johnson Matthey Company), Naloxone (Acent Scientific
Company), TramadolR (Searle Pakistan Ltd.). Sterile nor-
mal saline was used in all experiments as control while
methanolic extract was prepared in normal saline.
Animals
BALB/c mice of either sex were used in all experiments.
Animals were purchased from the Pharmacology Section
of the Department of Pharmacy, University of Peshawar,
Peshawar, Pakistan. The animals were maintained in
standard laboratory conditions (25°C and light/dark
cycles i.e. 12/12h) and were fed with standard food and
water ad libitum. The experimental protocols were
approved by the ethical committee of the Pharmacy De-
partment, University of Peshawar, Peshawar, Pakistan.
Plant material
Whole plant of V. betonicifolia was collected from Swat,
Khyber Pakhtunkhawa, Pakistan, in April 2010. Plant spe-
cimen was identified by Taxonomist, Department of Bot-
any, University of Peshawar and a specimen was deposited
there in the herbarium with voucher number 6410/Bot.
The collected whole plant (12kg) was air dried and pow-
der. The powder was extracted by maceration with metha-
nol at room temperature for 14days with occasional
shaking. The methanolic extract was filtered and concen-
trated under vacuum using rotary evaporator at low
temperature (45°C). The methanolic extract was dissolved
in distilled water and further fractionated with chloroform,
n-hexane, ethyl acetate, n-butanol and aqueous fractions.
Acute toxicity
The acute toxicity test was carried out for VBME to
evaluate any possible toxicity. BALB/c mice (n=6) of either
sex were treated with different doses (500, 1000 and
2000mg/kg, p.o.), while the control group received saline
(10ml/kg). All the groups were observed for any gross effect
for first 4h and then mortality was observed after 24h [10].
Antipyretic test
The antipyretic activity was evaluated for VBME using
BALB/c mice (25–30g) of either sex. The selected
animals were healthy and were acclimatized to laboratoryconditions before the start of experiment. The animals
were divided into five groups each of six mice. The nor-
mal body temperature of each mouse was recorded using
digital thermometer and then pyrexia was induced in all
mice by injecting 20% aqueous suspension of Brewer’s
yeast (10ml/kgs.c.). All groups were fasted overnight but
allowed free accesses to drinking water and after 24h
rectal temperature of each mouse was recorded. The in-
duction of pyrexia was confirmed by rise in temperature
more than 0.5°C, while animals showed rise in
temperature less than 0.5°C were excluded from experiment
[11]. Group I received saline (10ml/kg) as a negative
control, Group II received paracetamol (150mg/kg) as a
standard drug while the remaining groups III, IV and V
received 100, 200 and 300mg/kg i.p. VBME respectively.
After drugs administration, rectal temperature was again
recorded periodically at 1, 2, 3, 4 and 5h of drugs adminis-
tration. The percent reduction in pyrexia was calculated by
the following formula.
Percent reduction =B – Cn/B – A×100
Where, B represents temperature after pyrexia induction;
Cn temperature after 1, 2, 3, 4 and 5 h and A, normal body
temperature.
Analgesic activity
Acetic acid induced writhing test
BALB/c mice of either sex (n = 6) weighing 18–22g were
used. All animals were withdrawn from food 2h before
the start of experiment and were divided in five groups.
Group I was injected with normal saline (10ml/kg) as
control, Group II received standard drug diclofenac
sodium (10mg/kg) while the remaining groups III, IV
and V were injected with 100, 200 and 300mg/kg i.p. of
VBME respectively. After 30min of saline, diclofenac
sodium and plant extract injection, the animals were
treated i.p. with 1% acetic acid. The number of abdominal
constrictions (writhes) were counted after 5min of acetic
acid injection for the period of 10 min [10].
Hot plat test
BALB/c mice of either sex (n = 6) weighing 18–22g were
acclimatized to laboratory conditions one hour before
the start of experiment with food and water available ad
libitum. Animals were then subjected to pre-testing on
hot plat (Havard apparatus) maintained at 55 ± 0.1°C.
Animals having latency time greater than 15 s on hot
plate during pre-testing were rejected (latency time) [12].
All the animals were divided in eight groups each of six
mice. Group I was treated with saline (10ml/kg), group
II was treated with TramadolR (30mg/kg i.p). Group III,
IV and V were treated with 100, 200 and 300mg/kg
VBME, i.p. respectively. After 30min of treatment the
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(time for which mouse remains on the hot plate
(55 ± 0.1°C) without licking or flicking of hind limb or
jumping) was measured in seconds. In order to prevent
the tissue damage a cut-off time of 30 s were imposed
for all animals. To find out the opiodergic mechanism in
the analgesic activity of VBME, Groups VI and VII were
treated with naloxone (0.5mg/kg s.c.) and after 10min these
groups were treated with VBME (200 and 300mg/kg, i.p),
while group VIII was treated with TramadolR (30mg/kg i.p.)
after 10min of naloxone injection. The latency time for all
groups was recorded at 0, 30, 60, 90 and 120min. Percent
analgesia was calculated using the following formula:
% Analgesia = (Test latency – control latency)/(Cut –
off time – control latency) × 100
Tail immersion test
BALB/c mice of either sex were divided into five groups
each of six animals (18–22g). Saline (10ml/kg), VBME at
the dose of 100, 200 and 300mg/kg, and TramadolR
(30mg/kg) were administered intraperitoneally. The ani-
mal was kept in vertical position to hang the tail, which
was up to 5cm into a pot of hot water maintained at
55 ± 0.5°C. The time in seconds to withdraw the tail out
of water was taken as the reaction time (Ta). The reading
was taken after 0, 30, 60, 90 and 120min of administra-
tion of the test drugs [13]. The cut-off time, i.e. time of
no response was put at 30s, while Tb was consider the
reaction time for control group.
Percentage analgesic activity =Ta – Tb/Tb × 100
Anti-inflammatory activity
Carrageen induced paw edema
The anti-inflammatory activity was performed on mice
of either sex (25–30g). The animals were randomly
divided in five groups each of six animals [14]. Group I
was treated with normal saline (10ml/kg), group II with
diclofenac sodium (10mg/kg), rest of the groups were
treated with VBME (100, 200, and 300mg/kg, i.p). After
thirty minutes of the above intraperitoneal administra-
tion, carrageenan (1%, 0.05ml) was injected subcutane-
ously in the sub plantar tissue of the right hind paw of
each mouse. The inflammation was measured using
plethysmometer (LE 7500 plan lab S.L) immediately after
injection of carrageenan and then 1,2,3,4 and 5h. The
average foot swelling in drug treated animal as well as
standard was compared with that of control and the per-
cent inhibition (anti-inflammatory activity) of edema was
determined using the formula.
Percent inhibition=A-B/A×100, where A represent
edema volume of control and B as paw edema of tested
group.Histamine induced paw edema
Animals were divided as in the previous experiment and
inflammation was induced by subcutaneous injection of
0.1ml of freshly prepared solutions of histamine (1mg/ml)
into the hind paws of the mice [13]. The percent inhibition
of paw edema induced by each test sample was calculated
as described in case the carrageenan induced paw test.
Phytochemical status
Preliminary phytochemical tests were performed for
VBME. The presence of alkaloid content was determined
by performing Mayer’s test; white precipitate (ppt) indi-
cated the presence of alkaloids [15]. Flavonoids were
determined when addition of few drops of sodium
hydroxide solution, formed intense yellow coloration that
became colorless after addition of dilute acetic acid.
Saponins were identified by formation of froth upon
simple shaking (frothing test). Tannins and phenols were
identified on addition of ferric chloride to the extract
solution; the appearance of blue or green ppt indicated the
presence of tannins [16]. Sterols and triterpenoids were
identified on addition of few drops of acetic anhydride to
the extract solution, boiled, cooled and then add concen-
trated sulphuric acid, producing brown ring at the junction
of two layers, the turning of upper layer to green indicated
sterols and deep red color indicated triterpenoids [17].
Statistical analysis
The results obtained were expressed as mean ± SEM
(Standard error of mean) of six animals. For statistical
analysis, ANOVA was followed by post hoc Dunnett’s
test for multiple comparisons. Effects were considered to
be significant at the P< 0.05 level.
Results
Acute toxicity
VBME was found safe at all test doses (500, 1000 and
2000mg/kgi.p.). During 24h assessment time, test animals
were found normal.
Antipyretic test
The VBME markedly (P< 0.01) attenuated hyperthermia
induced by yeast. The inhibition was dose dependent
and remained significant up to 3h of administration as
shown in Table 1. The maximum antipyretic effect was
observed at 300mg/kg i.e. 78.23% while, the antipyretic
effect of paracetamol was 90%. The percent pyrexia
inhibition is shown in Figure 1.
Analgesic activity
Acetic acid induced test
The results showed that the pain relief was achieved in a
dose dependent manner, at all test doses (100, 200 and
300mg/kg i.p.) as shown in Table 2. Maximum inhibition




After administration of drug
Normal (A) after 24h (B) 1h (C1) 2h (C2) 3h (C3) 4h (C4) 5h (C5)
Saline 10mL 36.66 ± 0.11 38.92 ± 0.34 38.82 ± 0.21 38.78 ± 0.11 38.68 ± 0.20 38. 68 ± 0.20 38.72 ± 0.15
Paracetamol 150mg 37.08 ± 0.08 39.46 ± 0.04 38.20** ± 0.01 37.80** ± 0.03 37.30** ± 0.02 37.35 ** ± 0.28 37.38** ± 0.04
VBME 100mg 37.06 ± 0.02 39.70 ± 0.43 39.44 ± 0.22 38.98* ± 0.22 38.04** ± 0.11 38.16** ± 0.12 38.22** ± 0.11
200 37.00 ± 0.14 39.00 ± 0.11 38.68 ± 0.02 38.40*s ± 0.25 37.72** ± 0.45 37.80** ± 0.11 37.85 ± 0.41
300 37.02 ± 0.12 39.84 ± 0.20 39.30 ± 0.31 38.70* ± 0.12 37.64** ± 0.44 37.74** ± 0.10 37.80** ± 0.23
Data are reported as mean± S.E.M. for group of six animals. The data was analyzed by ANOVA followed by Dunnett’s test. Asterisks indicated statistically significant
values from control. *P< 0.05, **P< 0.01.
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percent inhibition of writhing is shown in Figure 2. The
inhibitory effect of paracetamol (96.22%) was greater
than that of the highest dose of VBME.Hot plat test
The results of the hot plat test revealed that the latency
time was significantly (P< 0.05) increased from 17.22% to
68.58% at the dose of 100 to 300mg/kg. The effect was
dose dependent and the maximum effect was observed
after 60min as shown in Table 3. The most significant
(P< 0.01) increase in latency time noticed against 300mg/
kg of VBME was 68.58% whereas, the percent inhibition of
the standard opioid analgesic (TramadolR) was 76.73% as
shown in Figure 3. In the presence of naloxone, the anal-
gesic effect of TramadolR (30mg/kg) and VBME (200 and





































Figure 1 Antipyretic effect of VBME in mice. Bar presents the
percent inhibition of pyrexia after 1,2,3,4 and 5h of the
treatment with paracetamol (150mg/kg) and VBME (100–
300mg/kg). The data was analyzed by ANOVA followed by
Dunnett’s test. Asterisks indicated statistically significant values from
control. *P< 0.05, **P< 0.01.Tail immersion test
The analgesic effect of the VBME was also significant
(P< 0.05) in tail immersion test and was dose dependent
like hot plat test. The reaction time of all doses and
TramadolR is given in Table 4. The maximum analgesic
effect was noticed at 60min after the dose administration.
The percent inhibition of pain was 17.22, 22.29 and 68.58 at
100, 200 and 300mg/kg of VBME respectively. TramadolR
which is a centrally acting opioid analgesic showed marked
activity (76.73%) as shown in Figure 5.Anti-inflammatory activity
Edema induced by Carrageenan
The anti-inflammatory activity at test doses (100, 200 and
300mg/kg i.p.) of VBME is presented in Table 5 with the
average volume of the paw edema. The percent protection
of inflammation is presented in Figure 6. The injection of
the carrageenan in paw created an inflammatory edema
which increased gradually. The VBME at the dose of
300mg/kg exhibited an anti-inflammatory activity that
became significant (P< 0.01) 2 h after the injection of
carrageenan and was maintained all along the experiment
with a maximum effect of 60.880%. The extract (200 and
300mg/kg) induced significant (P< 0.01) anti-inflammatory
effect and the anti-inflammatory effect of diclofenac sodium
(10mg/kg) was greater than that of the extract as presented
in Figure 6.Table 2 Effect of VBME 100, 200 and 300mg/kg in acetic
acid induced test
Treatment Dose (mg/kgi.p.) No. of writhing (10min)
Saline 10ml/kg 64.80 ± 2.68
Methanolic extract 100 38.80 ± 2.50**
200 28.00 ± 1.50**
300 20.00 ± 1.14**
Diclofenac 10 10.40 ± 1.36**
Values are reported as mean ± S.E.M. for group of six animals. The data was
analyzed by ANOVA followed by Dunnett’s test. Asterisks indicated statistically





























Figure 2 Percent analgesic activity of VBME (100, 200 and
300mg/kg) in acetic acid induce pain model. Bars present as
mean± S.E.M. of percent analgesia for group of six animals. The data
was analyzed by ANOVA followed by Dunnett's test. Asterisks
indicated statistically significant values from control. *P< 0.05,
**P< 0.01.
























Figure 3 Percent effect of VBME (100, 200 and 300mg/kg) and
TramadolR (30mg/kg) on hot plate pain in mice. Each point
represents the mean± SEM of 6 animals, The data was analyzed by
ANOVA followed by Dunnett’s test. Asterisks indicated statistically
significant values from control. *P< 0.05, **P< 0.01, **P< 0.001.
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The inflammatory edema induced by histamine was sig-
nificantly inhibited by VBME 200 and 300mg/kg. The
VBME showed a reasonable anti-inflammatory effect in a
dose dependent manner and remained significant up to 5th
h of administration as shown in Table 5 and Figure 7.
Phytochemical test
The VBME was found to contain alkaloids, saponins, fla-
vonoids, tannins, proteins, and phenolic compounds.
Discussion
Results of the present study showed that the VBME has
marked antipyretic, analgesic and anti-inflammatory
effects with a reasonable safety profile.
Subcutaneous injection of Brewer’s yeast induces pyrexia
by increasing the synthesis of prostaglandin. It is considered
as a useful test for the screening of plants materials as wellTable 3 Effect of VBME 100, 200 and 300mg/kg in hot plat te
Group Treatment/kg 0min 30min
Saline 10ml 9.20 ± 0.02 9.22 ± 0.08
VBME 100mg 9.21 ±0.23 11.92 ± 0.44
200mg 9.23 ±0.65 12.85 ± 0.87
300mg 9.24 ±0.76 19.76* ± 0.22
TramadolR 30mg 9.20 ±0.02 25.34** ± 0.0
Analgesic effect of TramadolR and VBME antagonized by Naloxone
VBME 300mg 9.21 ±0.45 10.78** ± 0.5
200mg 9.22 ±0.76 10.80** ± 0.8
TramadolR 30mg 9.23 ±0.02 10.22** ± 0.0
Values are reported as mean ± S.E.M. for group of six animals. The data was analyze
significant values from control. *P< 0.05, **P< 0.01, ***P< 0.001.as synthetic drugs for their antipyretic effect [14,18]. Yeast-
induced pyrexia is called pathogenic fever and its etiology
could be the production of prostaglandins [19]. The inhib-
ition of prostaglandin synthesis could be the possible mech-
anism of antipyretic action as that of paracetamol and the
inhibition of prostaglandin can be achieved by blocking the
cyclo-oxygenase enzyme activity. There are several media-
tors for pyrexia and the inhibition of these mediators are re-
sponsible for the antipyretic effect [20]. The intraperitoneal
administration of VBME significantly attenuated rectal
temperature of yeast induced febrile mice. Thus it can be
postulated that VBME contained pharmacologically active
principle(s) that interfere with the release of prostaglandins.
Furthermore, the presence of salicylic acids in the other
species of the genus Viola [21] and the antipyretic action of
the n-hexane fraction of Viola odorata [22] supplement the
antipyretic activity of our tested extract.st
60min 90min 120min
9.16 ± 0.09 9.20 ± 0.03 9.12 ± 0.11
13.20* ± 0.87 12.78* ± 0.46 12.58* ± 0.34
14.51** ± 0.54 14.30** ± 0.84 14.09** ± 0.91
23.74** ± 0.12 23.10** ± 0.12 22.98** ± 0.69
4 25.88*** ± 0.06 25.80*** ± 0.07 25.77*** ± 0.00
6 10.80** ± 0.39 10.91** ± 0.89 10.98** ± 0.78
7 10.75** ± 0.92 10.82** ± 0.72 10.86** ± 0.92
5 10.02*** ± 0.09 10.24*** ± 0.03 10.05*** ± 0.00
d by ANOVA followed by Dunnett’s test. Asterisks indicated statistically
























Figure 4 Percent effect of VBME (200 and 300mg/kg) and
TramadolR (30mg/kg) antagonized with naloxone (0.5mg/kg) on
hot plat pain model in mice. Each point represent the mean± SEM
of six animals. The data was analyzed by ANOVA followed by
Dunnett’s test. Asterisks indicated statistically significant values from
control. *P< 0.05, **P< 0.01, **P< 0.001.
























Figure 5 Percent effect of VBME (100, 200 and 300mg/kg) and
TramadolR (30mg/kg) on tail immersion pain in mice. Each point
represents the mean± SEM of 6 animals. The data was analyzed by
ANOVA followed by Dunnett’s test. Asterisks indicated statistically
significant values from control. *P< 0.05, **P< 0.01, ***P< 0.001.
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protocol in evaluating medicinal agents for their analgesic
property. The pain induction caused by liberating endogen-
ous substances as well as some other pain mediators such
as arachidonic acid via cyclooxygenase, and prostaglandin
biosynthesis [10,23]. This pain paradigm is widely used for
the assessment of peripheral analgesic activity due to its
sensitivity and response to the compounds at a dose which
is not effective in other methods. The local peritoneal re-
ceptor could be the cause of abdominal writhings [24]. Pain
sensation in acetic acid induced writhing paradigm is eli-
cited by producing localized inflammatory response due to
release of free arachidonic acid from tissue phospholipids
via cyclo-oxygenase (COX), and producing prostaglandin
specifically PGE2 and PGF2α, the level of lipoxygenase pro-
ducts may also increases in peritoneal fluids [10,23]. These
prostaglandin and lipoxygenase products cause inflamma-
tion and pain by increasing capillary permeability. The sub-
stance inhibiting the writhings will have analgesic effect
preferably by inhibition of prostaglandin synthesis, a periph-
eral mechanism of pain inhibition [23]. Regarding theTable 4 Effect of VBME 100, 200 and 300mg/kg in Tail immer
Group Per Kg 0min 30min
Saline 10ml 3.22 ± 0.02 3.23 ± 0.04
VBME 100 3.21 ± 0.87 3.54 ± 0.28
200 3.22 ± 0.28 3.58* ± 0.18
300 3.25 ± 0.27 4.82* ± 0.22
TramadolR 30mg 3.20 ± 0.01 5.60*** ± 0.03
Values are reported as mean ± S.E.M. for group of six animals. The data was analyze
significant values from control. *P< 0.05, **P< 0.01, ***P< 0.001.results of our extract in acetic acid-induced abdominal con-
striction assay, a prominent inhibition of writhing reflux
was observed. These findings strongly recommend that
VBME has peripheral analgesic activity and their mechan-
isms of action may be mediated through inhibition of local
peritoneal receptors which may be the involvement of
cyclooxygenase inhibition potential. The profound analgesic
activity of VBME may be due to the interference of their ac-
tive principle(s) with the release of pain mediators.
Thermal nociception models such as hot plat and the
tail immersion tests were used to evaluate central anal-
gesic activity. VBME showed significant (P< 0.01) anal-
gesic effect in both the hot plat and tail immersion tests,
implicating both spinal and supraspinal analgesic path-
ways. In these pain paradigms TramadolR, which is simi-
lar to the action of opioid agonists (e.g. morphine),
raised the pain threshold level within 30min of adminis-
tration. In contrast, VBME showed maximum analgesic
effect after 60min of administration. This difference in
the maximum analgesic point could be explained by dif-
ference in the metabolic rate of each drug or may be the
potency of each drug as the analgesic potential ofsion test
60min 90min 120min
3.31 ± 0.04 3.28 ± 0.10 3.25 ± 0.12
3.88* ± 0.28 3.79 * ± 0.67 3.71* ± 0.24
3.95** ± 0.23 3.91** ± 0.48 3.85 ** ± 0.97
5.58** ± 0.72 5.49 ** ± 0.76 5.41** ± 0.27
5.85*** ± 0.03 5.79*** ± 0.08 5.71*** ± 0.00
d by ANOVA followed by Dunnett’s test. Asterisks indicated statistically
Table 5 Effect of intraperitoneal administration of VBME at 100, 200 and 300mg/kg in carrageenan and histamine
induced paw edema test
Treatment Dose mg/kg NPS 0h 1h 2h 3h 4h 5h
Saline 10ml 0.0960 ± 0.22 0.2160± 0.24 0.2180 ± 0.12 0.2195± 0.20 0.2040± 0.14 0.2040 ± 0.18 0.2060± 0.17
Diclofenac 10mg 0.0900 ± 0.20 0.2180± 0.23 0.1487* ± 0.02 0.0980** ± 0.08 0.0499** ± 0.03 0.0620** ± 0.02 0.0821** ± 0.06
Anti-inflammatory effect against carrageenan induced paw edema
VBME 100 0.0920 ± 0.24 0.2140± 0.20 0.2020 ± 0.09 0.1902± 0.16 0.1499* ± 0.35 0.1580 ± 0.14 0.1680± 0.24
200 0.0980 ± 0.18 0.2060± 0.19 0.1723* ± 0.27 0.1500* ± 0.29 0.0998** ± 0.31 0.1145* ± 0.40 0.1240* ± 0.20
300 0.0980 ± 0.20 0.2190± 0.22 0.1680* ± 0.27 0.1247* ± 0.32 0.0799** ± 0.19 0.0940** ± 0.37 0.1009** ± 0.17
Anti-inflammatory effect against histamine induced paw edema
VBME 200 0.0970 ± 0.12 0.2070± 0.42 0.1628* ± 0.43 0.1520* ± 0.21 0.0999** ± 0.22 0.1091* ± 0.31 0.1109* ± 0.19
300 0.0967 ± 0.32 0.2092± 0.53 0.1185* ± 0.87 0.1155* ± 0.24 0.0810** ± 0.71 0.0905** ± 0.33 0.1013** ± 0.18
NPS (Normal Paw size). Values are reported as mean ± S.E.M. for group of six animals. The data was analyzed by ANOVA followed by Dunnett’s test. Asterisks
indicated statistically significant values from control. *P< 0.05, **P< 0.01.
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VBME showed a maximum effect after 60min and re-
main up to 120min in both thermal tests. When the non-
selective opioid receptor antagonist naloxone was
applied, the analgesic effect of VBME was also antago-
nized by naloxone after 30min of administration; it
means that the analgesic effect of this extract is due to
activation of the opioid receptor stimulation.
Carrageenan-induced paw edema is a well established
animal model to assess the anti-inflammatory effect of nat-
ural products as well as synthetic chemical compounds.
Edema formation due to carrageenan in paw is a biphasic
event, during 1–5h; the initial phase (1h or 1.5h) is pre-
dominately a non-phagocytic edema followed by a second








































Figure 6 Anti-inflammatory effect of VBME (100, 200 and
300mg/kg) in carrageenan induced paw edema in mice. Each
point percent inhibition of paw edema after 1,2,3,4 and 5h of
treatment. The data was analyzed by ANOVA followed by Dunnett’s
test. Asterisks indicated statistically significant values from control.
*P< 0.05, **P< 0.01.remained up to 5h [14,25]. The initial phase has been
induced due to the action of mediators such as histamine,
serotonin and bradykinin on vascular permeability [26].
The late phase or second phase edema has been shown to
be the result of overproduction of prostaglandins [27]. The
result of pre-treatment of VBME demonstrated that the ex-
tract (200 and 300mg/kg i.p.) is effective in the early phase
of inflammation which is due to release of histamine and
serotonin primarily. The anti-inflammatory effect of the ex-
tract remains significant up to 5th h of the experiment.
VBME showed significant activity against histamine induce
edema in both phases. During preliminary phytochemical
screening of the crude extract, important therapeutic prin-
ciples like alkaloids, saponins, flavonoids, tannins etc. were
































Figure 7 Anti-inflammatory effect of VBME (200 and 300mg/kg)
in histamine induced paw oedema model in mice. Bar presents
the percent inhibition of paw oedema after 1,2,3,4 and 5h of the
treatment. The data was analyzed by ANOVA followed by Dunnett’s
test. Asterisks indicated statistically significant values from control.
*P< 0.05, **P< 0.01.
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need on VBME to find the exact mechanism of action for
its antipyretic, analgesic and anti-inflammatory effects.
Conclusion
In conclusion, the methanolic extract of Viola betonicifolia
was proved a natural safe remedy for the treatment of pyr-
exia, algesia and inflammation. Our current findings
demonstrated scientific rationale for the folk use of the
plant as antipyretic, analgesic and anti-inflammatory.
Interestingly the VBME exhibited both peripheral as well
as central analgesic effect which might have been attribu-
ted to the presence of such active principles, due to which
it has proven folk use in various nervous disorders. Never-
theless, the isolation of pure secondary metabolites from
the plant will help us further in understanding the mech-
anism of these activities and identification of lead com-
pounds of clinical utility.
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